STANDARD BIOTOOLS INC. - COMMON STOCK

Standard BioTools Announces Appointment of Betsy Jensen as Chief Human Resources Officer

03 Jan 2023 08:30:59 By Nasdaq GlobeNewswire

Standard BioTools Authorizes up to $20 Million of Share Repurchases

28 Nov 2022 08:30:00 By Nasdaq GlobeNewswire

Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

22 Nov 2022 09:20:03 By Nasdaq GlobeNewswire

Standard BioTools Announces Third Quarter 2022 Financial Results

08 Nov 2022 16:05:02 By Nasdaq GlobeNewswire

Standard BioTools and Visiopharm Announce Partnership for the Development of Complete Image Analysis Solutions to be Packaged With Hyperion and Hyperion+ Imaging Systems

07 Nov 2022 16:05:02 By Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast of Third Quarter 2022 Financial Results

25 Oct 2022 08:30:01 By Nasdaq GlobeNewswire

Ascendas Genomics Receives NMPA Approval for Use of Standard BioTools Microfluidics Technology to Advance the Development of Molecular Diagnostics in China

13 Oct 2022 08:30:01 By Nasdaq GlobeNewswire

Standard BioTools Releases the X9 Real-Time PCR System, Its Most Productive and Flexible High-Capacity Genomics Platform

06 Oct 2022 08:30:01 By Nasdaq GlobeNewswire

Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

25 Aug 2022 16:05:00 By Nasdaq GlobeNewswire

Standard BioTools Announces Second Quarter 2022 Financial Results and Provides Strategic Update

08 Aug 2022 16:02:00 By Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast of Second Quarter 2022 Financial Results

25 Jul 2022 16:30:00 By Nasdaq GlobeNewswire

Standard BioTools Announces First Quarter 2022 Financial Results

05 May 2022 16:02:00 By Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast of First Quarter 2022 Financial Results

22 Apr 2022 16:02:00 By Nasdaq GlobeNewswire

Standard BioTools Launches Hyperion+ Imaging System, the New Standard in High-Plex Spatial Imaging

11 Apr 2022 08:30:00 By Nasdaq GlobeNewswire

Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 Apr 2022 19:15:24 By Nasdaq GlobeNewswire

Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.

04 Apr 2022 17:30:57 By Nasdaq GlobeNewswire

Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion

01 Apr 2022 16:05:00 By Nasdaq GlobeNewswire

Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global

29 Mar 2022 09:29:06 By Nasdaq GlobeNewswire

Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution

28 Mar 2022 08:30:00 By Nasdaq GlobeNewswire

Fluidigm Adjourns Special Meeting of Stockholders Until April 1, 2022

25 Mar 2022 16:00:00 By Nasdaq GlobeNewswire